PFE (Pfizer Inc.) Total Enterprise Value

Pfizer Inc. (PFE) is currently fighting for market share, aggressively acquiring oncology assets to combat generics. Management's effectiveness is being judged by its ability to diversify the portfolio and sustain profitability in the post-pandemic era. This price chart on the GURU.Markets platform shows Pfizer Inc. (PFE) with an Enterprise Value of 221590.28, while the business relies on external contractors for manufacturing and conducting research.

For Pfizer Inc. (PFE), which aggressively acquires biotech startups to refresh its patent portfolio, this metric reflects the actual cost of acquiring the entire business inclusive of its debt load. By analyzing the market value trend adjusted for net debt (market capitalization plus debt minus cash), an investor determines the fair value of the asset, avoiding overpayment for an inflated balance sheet when assessing the global reach of the company.